The prevailing approach to prevention of osteoporosis and bone fractures has entailed administration of estradiol, parathyroid hormone (PTH), and calcitonin, anti-resorptive drugs such as bisphosphonates and selective estrogen receptor modulators, and more recently, injections of anti-resorptive or anti-catabolic antibodies. The gene discussed is PTH; the disease is osteoporosis.